Copyright (c)
Shim Lab All Rights Reserved. Design by DSSO.KR

Paper

Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA
Author
Su-Eun Han, Hyungu Kang, Gayong Shim, Min Sung Suh, Sun Jae Kim, Jin-Seok Kim, Yu-Kyoung Oh
Journal
International Journal of Pharmaceutics (SCIE)
Vol
353
Page
260-269
Year
2008
양이온성 콜레스테롤 유도체를 이용한 siRNA전달용 리포좀 제제화 연구

Abstract
Most cationic liposomes used for gene delivery suffer from reduced transfection efficiency in the presence of serum. In this study, we report serum-enhanced delivery efficiency of siRNA via the use of newly synthesized liposomes that contain cationic lipids. Two cholesterol derivatives, cholesteryloxypropan-1-amine (COPA) and cholesteryl-2-aminoethylcarbamate (CAEC), were synthesized. A fluorescein label was then used to visualize cellular uptake of small interfering RNA (siRNA) via COPA or CAEC-based liposomes. The presence of serum had different effects on the cellular delivery of siRNA when siRNA was complexed to different cationic liposomes. CAEC-based liposomes showed significantly reduced cellular delivery of siRNA in serum-containing media as compared to serum-free media. Conversely, COPA-based liposomes (COPA-L) provided serum-enhanced delivery of siRNA in Hepa1–6, A549, and Hela cell lines. Following delivery of the oncogene survivin-specific siRNA, COPA-L reduced the mRNA expression levels of the target gene more efficiently than did Lipofectamine 2000. The delivery of green fluorescent proteinspecific siRNA with COPA-L reduced the expression of green fluorescent protein in 293T stable cell lines. The apoptosis of Hepa1–6 significantly increased by delivery of survivin-specific siRNA by COPA-L. Additionally, Hepa1–6, A549, and Hela cells were >80% viable after treatment with COPA-L. These results suggest that the newly synthesized cholesterol derivative, COPA-L, could be further developed as a serum-enhanced delivery system of siRNA.